Abridged from article by Peter J. Koehler, MD, PhD published 10 August 2017 in World Neurology Vol 32 No. 4, History of Neurology
From the history course at the American Academy of Neurology Annual Meeting 1
The term eponym is derived from the Greek words epi- "sur" and onima "name." It is hardly possible to imagine daily life without eponyms, although we are not always aware of using them. Just think of diesel engine, pasteurized milk, degrees Fahrenheit or Celsius, to name a few. Eponyms are found in nearly all sciences, including mathematics, astronomy, physics, chemistry, geography, palaeontology, and botany (to mention a few: Pythagoras, Gödel, Fourier analysis, Avogadro).
The use of eponyms is not new. Carl Linnaeus (1707-1778) used them in botany. Other eponyms became verbs (galvanize, faradize) or units (watt, ampère, ohm, joule). The French "préfet" (prefect) of the Seine department Eugène-René Poubelle made the use of garbage cans obligatory, hence the French word "poubelle" for garbage can.
A Dutch author estimated the number of eponyms in everyday language at 2,500-3,000. The Eponyms Dictionary Index features approximately 20,000 eponyms, including scientific eponyms.2
The choice of eponyms may tell something about the scientific evolution of the subject. Many eponyms in natural sciences, for instance, refer to persons from the 17th to 19th centuries, and the Scientific Revolution is supposed to have begun in the 17th century. As the scientific method in medicine was introduced in the mid-1800s, most medical eponyms find their origin after that period. Another interesting phenomenon to point to is that whereas 19th-century eponyms are often single names, those from the late 19th and 20th century mainly consist of several names.2
Medical eponyms are derived from various sources. They are not only named after the discoverer of a disease or microbe who is honoured (Borrelia Burgdorferi, Pick disease, Alzheimer's). Sources also include mythical figures (Ondine's curse, Oedipus complex), fairy tales (Alice-in-Wonderland syndrome), literature (Pickwick syndrome, Ophelia complex), artists (Brueghel syndrome), location (Lyme disease, Glasgow coma scale), and famous patients (Lou Gehrig).
The use of eponyms is not generally accepted. There are adversaries and advocates. London neurologist William Gowers (1845-1915) wrote that "this system of nomenclature is full of inconvenience, increasing the difficulties of the student, and leading to frequent mistakes in scientific writings," but he could not prohibit the use of his name in several eponyms4.
In his monograph on reflexes, Robert Wartenberg wrote that following the discovery by Joseph Babinski of the extensor plantar reflex, Wartenberg wrote about a plethora of discovered reflexes. |
In his monograph on reflexes, Robert Wartenberg (1886-1956) wrote that following the discovery by Joseph Babinski (1857-1932) of the extensor plantar reflex (1896), a plethora of reflexes was discovered. The discoverers probably hoped to see their names immortalized. (See Figure 1.)5, p.93
The mania to associate eponyms to reflexes and phenomena was particularly endemic in Europe. Wartenberg was in favour of descriptive terms. However, descriptive terms also have disadvantages, for instance, when the understanding of phenomena or diseases change. Interestingly, he could not prevent the usage of his name for eponyms (e.g., Wartenberg sign for pyramidal involvement of the upper extremity).
A pro-con discussion on the use of eponyms was conducted some years ago in the British Medical Journal.6 The authors, who stated that the use of eponyms should be abandoned, provided several reasons, mostly quoting a short selection of rare, disputable eponyms. Of course, they were right proposing the deletion of eponyms connected with Nazi medicine. Larry Zeidman and colleagues have done research in this area during the past 10 years.7 The arguments that some eponyms may bring about confusion or do not refer to the original discoverer is often heard and probably true. The person writing in favour of eponyms provided more general arguments, including the opinion that the eponym "brings colour to medicine," "provides a convenient shorthand," and are "embedded in medical traditions and culture in our history." She expected eponyms would stay, despite the objections of some. Probably the shorthand and reference to the historical person are the most important arguments provided in favour of the use of eponyms.8
Although done 20 years ago, a survey on neurological eponyms under Dutch neurologists (1997) provided interesting results. With 30 per cent of the addressed members responding, a positive correlation was found between age of the responders and the knowledge of eponyms. The best-known eponyms were found in the category "tests and manoeuvres." Many of the responding neurologists and residents did not prefer descriptive terms above eponyms.9
In another paper on neurological eponyms, the author mentioned the confusion that may arise when it is not clear whether the eponym refers to a syndrome or a disease. Moreover, there is an evolution of some of the eponyms, as our understanding of disease processes expands.10 There is even an eponym about the doubts of the origin: Stigler's law of eponymy states that "no scientific discovery is named after its original discover."11
At least from a historical perspective, there is still interest in eponyms. Entering the term "eponym" in PubMed and limiting the search to "history of medicine" provides 1,034 hits. Adding "neurology" results in 121 hits. And how is the use of eponyms in textbooks? The index of a neurological textbook, Adams and Victor's Principles of Neurology, counted 370 eponyms.12 Another example, Merritt's Neurology, did not yield much less.13
Many eponyms concern men. Even if the name refers to a woman, not everyone will realize this. In April 2017, Dr Stephen Reich, current chair of the History Section of the American Academy of Neurology, organized a history course in which eight eponymous women in neurology were presented. In the following section, I will summarize them.
Augusta Dejerine Klumpke and her husband. |
Born in San Francisco, Augusta Dejerine-Klumpke moved to Paris, where she studied medicine, and, not without difficulties, she became the first female intern of the Paris hospitals. She married Jules-Joseph Dejerine in 1888. She described the work by which she was eponymized in 1885 in the Revue de Médecine.14 It is about lower trunk brachial plexopathy with hand weakness. It is commonly associated with oculopupillary phenomena (Horner's syndrome). It is also referred to as Klumpke's paralysis. (The paper was presented by Jennifer McKinney.)
Gabrielle Lévy |
Born in Paris, where she studied medicine, Gabrielle Lévy became a pupil of Pierre Marie. She published on many subjects, the most important being post-encephalitic syndromes, which was also the subject of her 1922 thesis, and neuro-oncology, a subject she worked on when employed at the Paul-Brousse hospital that became an oncology center.
The eponym refers to a familial disease with gait problems, areflexia, and clubfoot (dystasie aréflexive héréditaire), today known to be caused either by a mutation in the PMP22 gene or the MPZ gene (as in the original family).15 Lévy died at age 48 from the disease that she had studied: a brain tumour or a post-encephalitic syndrome? (The paper was presented by Peter J. Koehler.)
Denise Louis-Bar (originally Bar, she married civil engineer F. Louis) published (in French) a case of this multisystem disease (ataxia, ocular-cutaneous telangiectasias, and immune deficiency) at age 27 (1941).16 Born in Liège, Belgium, she studied medicine in Brussels and trained under Ludo van Bogaert, with whom she studied the first case in Antwerp. Boder and Sedgwick published on eight children from five families in recognizing the hereditary character (1958).17 Louis-Bar later worked at the internal medicine department in Liège and was known there as "la rousse medical" (the medical red-haired). (The paper was presented by Elisabeth A. Coon.)